New study aims to predict breast cancer subtypes without needle biopsy
NCT ID NCT07354490
First seen Jan 22, 2026 · Last updated May 23, 2026 · Updated 18 times
Summary
This study looks at whether mammogram and ultrasound images can predict the molecular subtype of breast cancer (like Luminal A/B, HER2-enriched, or triple-negative) without needing a biopsy. Researchers will compare imaging features to lab results from 122 women with suspected or confirmed breast cancer. If successful, this could help guide treatment decisions faster and less invasively.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BREAST CANCER are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.